Skip to main content
OpenTrials
Completed

NCT Number: NCT01626365

Thermosoftening of Double-lumen Tube to Reduce Sore Throat

The purpose of this study is to investigate the effect of double-lumen tube thermosoftening before intubation to reduce postoperative hoarseness and sore throat.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients undergoing thoracic surgery that require the placement of left-sided double-lumen tubes

Exclusion criteria

  • Preoperative hoarseness or sore throat
  • History of upper airway diseases
  • Anticipated difficult airway
  • Anesthesia time longer than 6 hours

Treatment and study plan

non-thermosoftening

Procedure

Intubation is performed with a double-lumen tube put into normal saline at room temperature.

thermosoftening

Procedure

Intubation is performed with a double lumen tube put into warm normal saline (40°C).

Primary outcomes

  1. Postoperative hoarseness

    Time frame: up to 3 days after surgery

  2. postoperative sore throat

    Time frame: up to 3 days after surgery

Secondary outcomes

  1. Vocal cord injuries

    Time frame: up to 1 day after surgery

Sponsors and collaborators

Lead sponsor

Seoul National University Hospital

Other

Registry information

Official study title

The Effect of Double-lumen Tube Thermosoftening Before Intubation to Reduce Hoarseness and Sore Throat

Important dates

Study start
2012
Primary completion
2012
Study completion
2012
First posted
Jun 22, 2012
Registry last updated
Dec 18, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.